All News

DIP,OA

Why Would Hand OA Be Less Severe in Black People?

d MedPage Today

Osteoarthritis (OA) of the hand was less severe according to objective and pain-related markers in Black patients versus those of other racial/ethnic groups after adjustment for known risk factors, researchers found.

Read Article
VitD_1.jpg

Vitamin D and the Risk of Autoimmune Diseases

d Jack Cush, MD

The results of the VITAL study (presented at ACR 2021) are now published by BMJ, showing that vitamin D and omega 3 fatty acids reduce the overall risk of autoimmune disease (AID) in a population based intervention trial.

Read Article
computer screen safety

Methotrexate Side Effects

d Jack Cush, MD

Data came from the UK Rheumatoid Arthritis Medication Study (RAMS), a prospective cohort of early RA patients starting methotrexate (MTX) shows that in the first year, adverse events (AE) were common, but not serious.

Read Article
liveVote2.jpg

X-Linked Hypophophatemia - Survey Results

d Jack Cush, MD

The July 2021 RheumNow “Live Vote” surveyed US and non-US rheumatologists on their knowledge and practices when dealing with the bone disorder, X-linked hypophosphatemia (XLH).

Read Article
RheumNow Podcast square

An Ounce of Prevention (2.4.2022)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.  He discusses the GI side effects of IL-17 inhibitors, downstream revenues from rheumatology care and dietary prevention of gout. 

Read Article
pediatric.kid_.jpg

Pediatric Rheumatology Workforce Shortages

d Jack Cush, MD

Two recent analyses from the USA and Canada point to a significant unmet need with regard to pediatric rheumatologists.

Read Article
A prospective study of 124 pediatric SLE pts from UK - estimated Incidence 0.36/100 000. In 1st year 71% on systemic steroids, 98.2% on immunosuppressives, 20.4% accruing damage (mostly neuropsychiatric); most needing multiple speciality team care https://t.co/wdh52pn1Fd

Links:

Dr. John Cush RheumNow ( View Tweet)

Prevalence of PsA, axSpA & RA (2017) in Norwegian adults is 0.46%, 0.41%, & 0.78%. In 2017, 27.3% of RA patients, 25.7% of PsA patients and 35.1% of axSpA patients used biologic DMARDs (biologics more freq in youngers; infrequent if ≥55 yrs https://t.co/oqlpPmam6R

Links:

Dr. John Cush RheumNow ( View Tweet)

Hip fractures in elderly occur at >250 000/YR in US w/ a 1-yr mortality rate, 12%-37%. During COVID-19, surgery volumes among older individuals were lower than 2 years previously starting spring 2020 until vaccine was widely available https://t.co/80YQq1gyhA

Links:

Dr. John Cush RheumNow ( View Tweet)

The July 2021 RheumNow “Live Vote” surveyed US and non-US rheumatologists on their knowledge and practices when dealing with the bone disorder, X-linked hypophosphatemia (XLH). https://t.co/6ztalAZrII https://t.co/ONXaGJI15v

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Radiographic progression in AxSpA studied in 101 Spanish Pts - pts w/ sustained low ASDAS had less XRay progression than those with active Dz (2.33 vs 1.76, p=0.027). Long term TNFi use didnt influence progression until the 3rd Yr https://t.co/TchcLL2ivN

Links:

Dr. John Cush RheumNow ( View Tweet)

Despite guidelines rec against hyaluronic acid knee injections, HA injx by ortho significantly increased from 1,090,503 in 2012 to 1,209,489 in 2018 (p = 0.04).amongsts Medicare beneficiaries https://t.co/fIEb5pq20I

Links:

Dr. John Cush RheumNow ( View Tweet)

Psychosis is rare in SLE; Retrospective cohort review finds 18/709 SLE or 2.5% developed lupus psychosis. Psychosis remitted in 12/18 w/ a combo of antipsyschotic (in 38.9%) and immunosuppressive (steroid 72%, CTX 56%, RTX 17%, etc) https://t.co/AnCPaPS8QE

Links:

Dr. John Cush RheumNow ( View Tweet)

BMJ reports that dementia is associated with multimorbidity (>2 chronic diseases) in midlife (before ge 55 yrs)rather than late life; and greater risk with greater multimorbidity before 55 yrs. https://t.co/hCo8b8ufYG

Links:

Dr. John Cush RheumNow ( View Tweet)

We are excited to announce that Dr. Philip Mease will be joining us at RheumNow Live, leading a presentation and discussion on Axial Psoriatic Arthritis & Fatigue and Central Sensitization. Join the discussion on March 19-20, on site or virtually! https://t.co/3CeULLDgf5 https://t.co/M2ZUoXzlAK

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Top Tweet in January Clinical trials generally fail in Sjögren's syndrome; but now a study shows that a biologic B cell inhibitor, ianalumab, met its primary endpoint with a dose-related decrease in disease activity (measured by ESSDAI) at week 24. https://t.co/SLn2qs8En4 https://t.co/nMOUm2C9It

Links:

Dr. John Cush RheumNow ( View Tweet)
TB is uncommon in idiopathic inflamm myopathies (3.58%), esp in endemic areas (eg, Asia). Disseminated and Extra-pulmonary (47%) was as common as pulmonary TB (49%); TB Muscle dz seen in 24%. More with M. TB than Non-tuberculous Mycobacteria https://t.co/h6uDsdWj3f

Links:

Dr. John Cush RheumNow ( View Tweet)

Retrospective study of 84 pts with Erosive Hand OsteoArthritis (EHOA)- 89% females DIPs erosions scores were higher than PIP’s. Comorbid dz = crystal arthritis (8%), RA (5%) & PsA (1%), Pain usually >5/10 w/ 1/3 responding to NSAIDs. Big Unmet need! https://t.co/jQ3yNgaZBA

Links:

Dr. John Cush RheumNow ( View Tweet)

Treatment of Complex regional pain syndrome type-I (CRPS-I) in adults is difficult! A Systematic review shows that only parenteral bisphosphonates (and maybe ketamine) lowered VAS/NRS pain scales vs placebo. https://t.co/m4SpO4P96J

Links:

Dr. John Cush RheumNow ( View Tweet)

Persons living with diagnosed HIV (PLWDH) have more hospitalizations and death from COVID-19 than those not HIV+. In 100K PLWDH, 63%) were fully vaccinated, 4% partly Vax & 32% no Vax. VAX in PLWDH was lower than gen population (63% vs 75%) https://t.co/oegf5WjmNF

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×